{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:11:36Z","timestamp":1789506696833,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011833","name":"Guangxi University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128935","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:48:40Z","timestamp":1784130520000},"page":"128935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Economic evaluation of alternative PCV13 vaccination strategies in Guangxi, China: a decision tree\u2013Markov model study"],"prefix":"10.1016","volume":"88","author":[{"given":"Quan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangjun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenren","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9966","key":"10.1016\/j.vaccine.2026.128935_bb0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000-2013, with projections to inform post-2015 priorities: an updated systematic analysis","volume":"385","author":"Liu","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128935_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41479-024-00141-z","article-title":"Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in China among children under 14 years of age post-implementation of the PCV13: a systematic review and meta-analysis (2017-2024)","volume":"16","author":"Li","year":"2024","journal-title":"Pneumonia (Nathan)"},{"issue":"9693","key":"10.1016\/j.vaccine.2026.128935_bb0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128935_bb0020","first-page":"217","article-title":"Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines","volume":"16","author":"Lynch","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"14","key":"10.1016\/j.vaccine.2026.128935_bb0025","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper\u20142012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"45","key":"10.1016\/j.vaccine.2026.128935_bb0030","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.15585\/mmwr.mm6945a7","article-title":"Routine vaccination coverage\u2014worldwide, 2019","volume":"69","author":"Hill","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128935_bb0035","author":"Centers for Disease Control and Prevention"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128935_bb0040","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1080\/21645515.2020.1870396","article-title":"Cost-effectiveness analysis of domestic 13-valent pneumococcal conjugate vaccine for children under 5 years of age in mainland China","volume":"17","author":"Wang","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128935_bb0045","article-title":"Clinical outcomes and long-term sequelae of pneumococcal meningitis in Chinese children","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128935_bb0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12887-025-05476-0","article-title":"Clinical features and long-term outcomes of children with pneumococcal meningitis in China: a 10-year single-Centre retrospective analysis","volume":"25","author":"Li","year":"2025","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2026.128935_bb0055","series-title":"Decision modelling for health economic evaluation","author":"Briggs","year":"2006"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128935_bb0060","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128935_bb0065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/hec.770","article-title":"Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation","volume":"12","author":"Karnon","year":"2003","journal-title":"Health Econ"},{"key":"10.1016\/j.vaccine.2026.128935_bb0070","series-title":"Decision making in health and medicine: integrating evidence and values","author":"Hunink","year":"2014"},{"key":"10.1016\/j.vaccine.2026.128935_bb0075","series-title":"Guangxi statistical yearbook 2024","author":"Guangxi Zhuang Autonomous Region Bureau of Statistics","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128935_bb0080","series-title":"Statistical Communiqu\u00e9 on the 2024 National Economic and Social Development of Guangxi Zhuang Autonomous Region","author":"Guangxi Zhuang Autonomous Region Bureau of Statistics","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128935_bb0085","series-title":"Statistical Communiqu\u00e9 on the Development of Health Services in Guangxi Zhuang Autonomous Region, 2024","author":"Guangxi Zhuang Autonomous Region Health Commission","year":"2024"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128935_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201245","article-title":"Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China","volume":"13","author":"Shen","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128935_bb0095","author":"National Bureau of Statistics of China"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128935_bb0100","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s40121-023-00878-y","article-title":"Disease burden of meningitis caused by Streptococcus pneumoniae among under-fives in China: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128935_bb0105","first-page":"28","article-title":"Epidemiological surveillance of bacterial meningitis among children under 5 years of age in Nanning, Guangxi","volume":"25","author":"Dong","year":"2004","journal-title":"Chin J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128935_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027333","article-title":"Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature review","volume":"6","author":"Chen","year":"2011","journal-title":"PloS One"},{"issue":"20","key":"10.1016\/j.vaccine.2026.128935_bb0115","first-page":"2958","article-title":"Pathogen distribution among 18,386 cases of community-acquired pneumonia in children","volume":"36","author":"Liang","year":"2025","journal-title":"Hainan Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128935_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078489","article-title":"Incidence of community-acquired pneumonia among children under 5 years in Suzhou, China: a hospital-based cohort study","volume":"14","author":"Qian","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2026.128935_bb0125","series-title":"Economic evaluation of five non-national immunization program vaccines in China","author":"Fang","year":"2021"},{"key":"10.1016\/j.vaccine.2026.128935_bb0130","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2147\/IDR.S193671","article-title":"Prognostic factors in pediatric pneumococcal meningitis patients in mainland China: a retrospective multicenter study","volume":"12","author":"Wang","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2026.128935_bb0135","article-title":"A multicenter clinical epidemiology of pediatric pneumococcal meningitis in China: results from the Chinese Pediatric Bacterial Meningitis Surveillance (CPBMS) 2019\u20132020","volume":"14","author":"Wang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128935_bb0140","first-page":"149","article-title":"Prospective study and cost-effectiveness analysis of 23-valent pneumococcal polysaccharide vaccine among adults aged \u226560 years in Jiading District","volume":"38","author":"Pan","year":"2018","journal-title":"Chin J Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128935_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2332670","article-title":"Invasive pneumococcal diseases in Chinese children: a multicentre hospital-based active surveillance from 2019 to 2021","volume":"13","author":"Ning","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128935_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-09493-9","article-title":"Clinical characteristics and risk factors for poor outcomes of invasive pneumococcal disease in pediatric patients in China","volume":"24","author":"Fu","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"9546","key":"10.1016\/j.vaccine.2026.128935_bb0155","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128935_bb0160","article-title":"Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age","volume":"4","author":"Lucero","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128935_bb0165","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/epi.17976","article-title":"Development of an international standard set of outcomes and measurement methods for routine practice for infants, children, and adolescents with epilepsy","volume":"65","author":"Mitchell","year":"2024","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128935_bb0170","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1007\/s11136-024-03771-4","article-title":"Correction: development of algorithms for estimating the Child Health Utility 9D from caregiver priorities and Child Health Index of Life with Disabilities","volume":"33","author":"Tonmukayakul","year":"2024","journal-title":"Qual Life Res"},{"issue":"435","key":"10.1016\/j.vaccine.2026.128935_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1651-2227.2000.tb00775.x","article-title":"Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: a 19-year nationwide surveillance study","volume":"89","author":"Kaltoft","year":"2000","journal-title":"Acta Paediatr Suppl"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128935_bb0180","doi-asserted-by":"crossref","first-page":"e1062","DOI":"10.1093\/cid\/ciac475","article-title":"Distribution of serotypes causing invasive pneumococcal disease in children from high-income countries and the impact of pediatric pneumococcal vaccination","volume":"76","author":"Grant","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128935_bb0185","article-title":"Analysis of adverse events post-13-valent pneumococcal vaccination among children in Hangzhou, China","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128935_bb0190","series-title":"WHO guide for standardization of economic evaluations of immunization programmes","author":"World Health Organization","year":"2019"},{"issue":"18","key":"10.1016\/j.vaccine.2026.128935_bb0195","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128935_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128935_bb0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.46234\/ccdcw2023.072","article-title":"Coverage of 13-valent pneumococcal conjugate vaccine among children 0-15 months of age\u20149 provinces, China, 2019-2021","volume":"5","author":"Liu","year":"2023","journal-title":"China CDC Wkly"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128935_bb0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.vaccine.2012.10.103","article-title":"Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review","volume":"31","author":"Ozawa","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128935_bb0215","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3201\/eid2706.204238","article-title":"Twenty-year public health impact of 7- and 13-valent pneumococcal conjugate vaccines in US children","volume":"27","author":"Wasserman","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128935_bb0220","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s40121-023-00798-x","article-title":"Historical population-level impact of infant 13-valent pneumococcal conjugate vaccine national immunization programs on invasive pneumococcal disease","volume":"12","author":"Perdrizet","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2026.128935_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127138","article-title":"Nationwide population-based surveillance of invasive pneumococcal disease in children in Japan (2014-2022)","volume":"54","author":"Takeuchi","year":"2025","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128935_bb0230","first-page":"198","article-title":"Cost-effectiveness analysis of including the 13-valent pneumococcal conjugate vaccine in the immunization program in Qinghai Province based on a decision tree\u2013Markov model","volume":"30","author":"Guo","year":"2024","journal-title":"Chin J Vaccin Immun"},{"key":"10.1016\/j.vaccine.2026.128935_bb0235","series-title":"Guide for standardization of economic evaluations of immunization programmes","author":"World Health Organization","year":"2019"},{"issue":"1 Suppl","key":"10.1016\/j.vaccine.2026.128935_bb0240","first-page":"S15","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccine in Taiwan: a transmission dynamic modeling approach","volume":"15","author":"Wu","year":"2012","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128935_bb0245","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2214-109X(18)30422-4","article-title":"Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128935_bb0250","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/ciy129","article-title":"Effectiveness of 7- and 13-valent pneumococcal conjugate vaccines in a schedule without a booster dose: a 10-year observational study","volume":"67","author":"Jayasinghe","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:40:12Z","timestamp":1789504812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S0264410X26007449"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128935","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation of alternative PCV13 vaccination strategies in Guangxi, China: a decision tree\u2013Markov model study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128935"}}